<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02820779</url>
  </required_header>
  <id_info>
    <org_study_id>COVER 001</org_study_id>
    <nct_id>NCT02820779</nct_id>
  </id_info>
  <brief_title>New Covered Stent (Willis) for the Endovascular Reconstruction of Intracranial Vessel Wall Defects Registry</brief_title>
  <acronym>COVER</acronym>
  <official_title>New Covered Stent (Willis) for the Endovascular Reconstruction of Intracranial Vessel Wall Defects Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xuanwu Hospital, Beijing</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>First Affiliated Hospital of Harbin Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Second Affiliated Hospital of Harbin Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Qilu Hospital of Shandong University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai Tongji Hospital, Tongji University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nanfang Hospital of Southern Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tang-Du Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>West China Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Zhengzhou University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shaanxi Provincial People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shandong Provincial Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital of Xinjiang Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Xuanwu Hospital, Beijing</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effectiveness, long-term safety and explore the
      safety and efficacy factors WILLIS™ intracranial stent graft system in clinical applications.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Intracranial aneurysm is a cerebrovascular disorder in which weakness in the wall of a
      cerebral artery or vein causes a localized dilation or ballooning of the blood vessel.WILLIS®
      intracranial stent graft system is indicated for the treatment of intracranial aneurysms.

      This study is a multi-center, prospective registration study.

      Recruiting 100 specific patients to undergo a treatment with the WILLIS intracranial stent
      graft system, while giving the anti-platelet aggregation drugs and other medical therapy.

      Patients enrolled will undergo a one-year follow-up.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">May 2019</completion_date>
  <primary_completion_date type="Anticipated">May 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>1-year treatment success rate</measure>
    <time_frame>12 months</time_frame>
    <description>Treatment success is defined as target lesion such as aneurysms, cavernous fistula shows no shadow and target vessel stenosis of no more than 50%.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Technically success rate of surgery</measure>
    <time_frame>immediately after surgery</time_frame>
    <description>Technically success is defined as stent reach the target lesion and successfully released.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target lesion treatment success rate</measure>
    <time_frame>Immediately after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>X-ray exposure time</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative time</measure>
    <time_frame>through surgery completion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgery-related complications or death</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Various causes of death</measure>
    <time_frame>the perioperative period to 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrence of target lesion</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target lesion was treated by interventional or surgical therapy once again</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative ipsilateral symptomatic stroke</measure>
    <time_frame>30 days; 6 months; 12 months</time_frame>
    <description>Ipsilateral symptomatic stroke is defined as the target lesion is conformed occurs ipsilateral stroke and the increase of NIHSS score point ≥4.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurs intracranial hemorrhagic stroke that caused by aneurysm rupture</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurs intracranial ischemic stroke that caused by thrombus</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All adverse events</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Device-related serious adverse events</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target lesion appears stenosis 12 months after surgery</measure>
    <time_frame>12 months</time_frame>
    <description>Stenosis is defined as target stenosis ≥50%</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Rankin Scale</measure>
    <time_frame>30 days; 6 months; 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NIHSS</measure>
    <time_frame>30 days; 6 months; 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Aneurysm, Intracranial</condition>
  <condition>Carotid-Cavernous Sinus Fistula</condition>
  <arm_group>
    <arm_group_label>WILLIS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients undergo WILLIS intracranial covered stent interventional treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>WILLIS</intervention_name>
    <description>WILLIS® intracranial stent graft system is composed of the stent, delivery system, cobalt-based alloy stent and PTFE graft. It can effectively shunt the blood flow and keep it off of the aneurysm wall.</description>
    <arm_group_label>WILLIS</arm_group_label>
    <other_name>WILLIS® intracranial stent graft system</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age over 18;

          -  Arterial wall defects conformed by imaging examination due to internal carotid artery,
             vertebral artery aneurysms or various causes;

          -  Target lesion vessel reference diameter 3.5-4.5mm;

          -  Investigators believe that the patient is suitable for the interventional therapy of
             WILLIS intracranial covered stent;

          -  Participate in the study voluntarily, accept follow up study and signed Informed
             Consent Form.

        Exclusion Criteria:

          -  Existence of branch artery (eg anterior choroidal artery, posterior communicating
             artery, posterior inferior cerebellar artery, etc.) of target lesion which may cause
             severe neurological dysfunction after occlusion;

          -  No suitable vessel entrance, or diseased artery extremely tortuous;

          -  Coagulation disorders or serious heart, liver, kidney dysfunction or systemic
             infection, which not suitable for interventional treatment;

          -  Life expectancy &lt;1 year;

          -  Contraindications to heparin, aspirin, clopidogrel, anesthesia, X-ray or contrast
             agents;

          -  Mental disorder
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hongqi Zhang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>hqzh@vip.163.com</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hongqi Zhang, MD</last_name>
    <email>hqzh@vip.163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Nanfang hospital, Southern Medical university</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510515</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The 2nd Affiliated Hospital of Harbin Medical university</name>
      <address>
        <city>Harbin</city>
        <state>Heilongjiang</state>
        <zip>150001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Harbin Medical university</name>
      <address>
        <city>Harbin</city>
        <state>Heilongjiang</state>
        <zip>150001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>First Affiliated Hospital of Zhengzhou University</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <zip>450052</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Qilu Hospital Of Shang Dong University</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>250012</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Shandong Provincial Hospital</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>250021</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>ShanXi Provincial People's Hospital</name>
      <address>
        <city>Taiyuan</city>
        <state>Shanxi</state>
        <zip>030012</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Tangdu Hospital Fourth Military Medical University</name>
      <address>
        <city>Xi'an</city>
        <state>Shanxi</state>
        <zip>710038</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>West China Hospital Sichuan University</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610041</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital Of Xinjiang Medical University</name>
      <address>
        <city>Urumqi</city>
        <state>Xinjiang</state>
        <zip>830054</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Tongji Hospital</name>
      <address>
        <city>Shanghai</city>
        <zip>200333</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 23, 2016</study_first_submitted>
  <study_first_submitted_qc>June 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 1, 2016</study_first_posted>
  <last_update_submitted>June 28, 2016</last_update_submitted>
  <last_update_submitted_qc>June 28, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Xuanwu Hospital, Beijing</investigator_affiliation>
    <investigator_full_name>Hongqi Zhang, MD</investigator_full_name>
    <investigator_title>Cerebrovascular Expert Committee of Chinese Medical Doctor Association</investigator_title>
  </responsible_party>
  <keyword>Willis</keyword>
  <keyword>Intracranial aneurysms</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Fistula</mesh_term>
    <mesh_term>Intracranial Aneurysm</mesh_term>
    <mesh_term>Carotid-Cavernous Sinus Fistula</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

